Melatonin and its agonist ramelteon in Alzheimer's disease : possible therapeutic value
Abstract: Alzheimer’s disease (AD) is an age-associated neurodegenerative disease characterized by the progressive loss of cognitive function, loss of memory and insomnia, and abnormal behavioral signs and symptoms. Among the various theories that have been put forth to explain the pathophysiology o...
Guardado en:
| Autores principales: | Srinivasan, Venkataramanujan, Pandi Perumal, Seithikurippu R., Kaur, Charanjit, Brown, Gregory M., Cardinali, Daniel Pedro |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1645 |
| Aporte de: |
Ejemplares similares
-
Melatonin agonists for treatment of sleep and depressive disorders
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019) -
Melatonin and its analogs in insomnia and depression
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2019) -
Melatonin agonists in primary insomnia and depression-associated insomnia : are they superior to sedative-hypnotics?
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019) -
Jet lag, circadian rhythm sleep disturbances and depression : the role of melatonin and its analogs
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)